Literature DB >> 3115193

Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis.

K Herrmann, E Schulze, U F Haustein, H J Böhme, V Ziegler.   

Abstract

In 14 patients with progressive systemic sclerosis (PSS) the activities of acid lysosomal glycosidases (alpha-, beta-galactosidase, beta-glucosidase, beta-glucuronidase, and beta-N-acetyl-glucosaminidase) were determined fluorometrically in serum, leukocytes, and skin tissue. The beta-galactosidase was the only enzyme which exhibited a significantly elevated activity in PSS serum and skin but not leukocytes, as compared to the control. The activity patterns of the studied glycosidases in serum were similar to those found in skin, but differ from the distribution of glycosidase activities in leukocytes. In cultured dermal fibroblasts derived from PSS patients, an elevated intracellular activity of beta-galactosidase was detected. These results suggest that the increased beta-galactosidase activity in the serum originates from the skin fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115193     DOI: 10.1007/bf00431221

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  [Morphology, biochemistry and function of proteoglycans in the skin].

Authors:  H W Kreysel
Journal:  Hautarzt       Date:  1975-03       Impact factor: 0.751

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Pathways of protein secretion in eukaryotes.

Authors:  R B Kelly
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

Review 4.  Pathogenesis of progressive systemic sclerosis.

Authors:  U F Haustein; K Herrmann; H J Böhme
Journal:  Int J Dermatol       Date:  1986-06       Impact factor: 2.736

5.  Immunologic enhancement of collagen accumulation in progressive systemic sclerosis (PSS).

Authors:  M K Cathcart; R S Krakauer
Journal:  Clin Immunol Immunopathol       Date:  1981-10

6.  Macrophage-fibroblast interactions in collagenase production and cartilage degradation.

Authors:  G Huybrechts-Godin; P Hauser; G Vaes
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

7.  Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis.

Authors:  R E Gay; R B Buckingham; R K Prince; S Gay; G P Rodnan; E J Miller
Journal:  Arthritis Rheum       Date:  1980-02

8.  Immunohistochemical demonstration of proteoglycans in the skin of patients with systemic sclerosis.

Authors:  M Kitabatake; H Ishikawa; H Maeda
Journal:  Br J Dermatol       Date:  1983-03       Impact factor: 9.302

9.  Acid lysosomal hydrolases in systemic sclerosis and other connective tissue diseases.

Authors:  K Herrmann; U F Haustein; H J Böhme; I Lohrisch
Journal:  Br J Dermatol       Date:  1982-05       Impact factor: 9.302

10.  Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.

Authors:  R B Buckingham; R K Prince; G P Rodnan
Journal:  J Lab Clin Med       Date:  1983-05
View more
  1 in total

Review 1.  The immunopathology of siliconosis. History, clinical presentation, and relation to silicosis and the chemistry of silicon and silicone.

Authors:  D R Shanklin; D L Smalley
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.